Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer

Radiotherapy and Oncology

Volumn 93, Issue 2, 2009, Pages 234-240

  Seppälä, Jan ^a   Seppänen, Marko ^a   Arponen, Eveliina ^a   Lindholm, Paula ^a   Minn, Heikki ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Acetate; Dose escalation; PET; Probability of uncomplicated control; Prostate cancer

Indexed keywords

ACETIC ACID DERIVATIVE; CARBON 11; CARBON 11 ACETATE; CONTRAST MEDIUM; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; CANCER RADIOTHERAPY; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEASIBILITY STUDY; HUMAN; IMAGE ANALYSIS; INTENSITY MODULATED RADIATION THERAPY; MALE; ORGAN SIZE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RECTUM; TREATMENT PLANNING;

ACETATES; CARBON; CARBON RADIOISOTOPES; HUMANS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 70350504880     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.010     Document Type: Article

References (38)

1. Kupelian P.A., Ciezki J., Reddy C.A., Klein E.A., and Mahadevan A. Effect of increasing radiation doses on local and distant failures in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 71 (2008) 16-22
2. Zelefsky M.J., Yamada Y., Fuks Z., et al. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes. Int J Radiat Oncol Biol Phys 71 (2008) 1028-1033
3. Eade T.N., Hanlon A.L., Horwitz E.M., et al. What dose of external-beam radiation is high enough for prostate cancer?. Int J Radiat Oncol Biol Phys 68 (2007) 682-689
4. Kuban D.A., Tucker S.L., Dong L., et al. Long-term results of the M.D. Anderson randomized dose-escalation trial for prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 67-74
5. Zelefsky M.J., Levin E.J., Hunt M., et al. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 1124-1129
6. van Lin E.N., Fütterer J.J., Heijmink S.W., et al. IMRT boost dose planning on dominant intraprostatic lesions: gold marker-based three-dimensional fusion of CT with dynamic contrast-enhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65 (2006) 291-303
7. Fonteyne V., Villeirs G., Speleers B., et al. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion. Int J Radiat Oncol Biol Phys 72 (2008) 799-807
8. Lian J., Xing L., Hunjan S., et al. Mapping of the prostate in endorectal coil-based MRI/MRSI and CT: a deformable registration and validation study. Med Phys 31 (2004) 3087-3094
9. Oyama N., Akino H., Kanamaru H., et al. 11C-acetate PET imaging of prostate cancer. J Nucl Med 43 (2002) 181-186
10. Morris M.J., and Scher H.I. (11)C-acetate PET imaging in prostate cancer. Eur J Nucl Med Mol Imaging 34 (2007) 181-184
11. Vees H., Buchegger F., Albrecht S., et al. 18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy. BJU Int 99 (2007) 1415-1420
12. Yamaguchi T., Lee J., Uemura H., et al. Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging 32 (2005) 742-748
13. Hara T., Bansal A., and DeGrado T.R. Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells. Nucl Med Biol 33 (2006) 977-984
14. Oyama N., Miller T.R., Dehdashti F., et al. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J Nucl Med 44 (2003) 549-555
15. Kato T., Tsukamoto E., Kuge Y., et al. Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med Mol Imaging. 29 (2002) 1492-1495
16. Schiepers C., Hoh C.K., Nuyts J., et al. 1-11C-acetate kinetics of prostate cancer. J Nucl Med 49 (2008) 206-215
17. Wachter S., Tomek S., Kurtaran A., et al. 11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer. J Clin Oncol 24 (2006) 2513-2519
18. Ciernik I.F., Brown D.W., Schmid D., et al. 3D-segmentation of the 18F-choline PET signal for target volume definition in radiation therapy of the prostate. Technol Cancer Res Treat 6 (2007) 23-30
19. Pike V.W., Eakins M.N., Allan R.M., and Selwyn A.P. Preparation of [1-11C]acetate - an agent for the study of myocardial metabolism by positron emission tomography. Int J Appl Radiat Isot 33 (1982) 505-512
20. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res 104 (1985) S13-S19
21. Kutcher G.J., Burman C., Brewster L., Goitein M., and Mohan R. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys 21 (1991) 137-146
22. Söhn M., Yan D., Liang J., et al. Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models. Int J Radiat Oncol Biol Phys 67 (2007) 1066-1073
23. Marks L.B., Carroll P.R., Dugan T.C., and Anscher M.S. The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31 (1995) 1257-1280
24. Brenner D.J. Fractionation and late rectal toxicity. Int J Radiat Oncol Biol Phys 60 (2004) 1013-1015
25. Zaider M., and Minerbo G.N. Tumour control probability: a formulation applicable to any temporal protocol of dose delivery. Phys Med Biol 45 (2000) 279-293
26. Stavreva N.A., Warkentin B., Stavrev P.V., and Fallone B.G. Investigating the effect of clonogen resensitization on the tumor response to fractionated external radiotherapy. Med Phys 32 (2005 Mar) 720-725
27. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys 24 (1997) 103-110
28. Wang J.Z., Guerrero M., and Li X.A. How low is the alpha/beta ratio for prostate cancer?. Int J Radiat Oncol Biol Phys 55 (2003) 194-203
29. Ågren A., Brahme A., and Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 19 (1990) 1077-1085
30. Dearnaley D.P., Hall E., Lawrence D., et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 92 (2005) 488-498
31. Cellini N., Morganti A.G., Mattiucci G.C., et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 53 (2002) 595-599
32. Soret M., Bacharach S.L., and Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 48 (2007) 932-945
33. Chen M.E., Johnston D.A., Tang K., Babaian R.J., and Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer 89 (2000) 1800-1809
34. Brenner D.J., and Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys 43 (1999) 1095-1101
35. Fowler J., Chappell R., and Ritter M. Is alpha/beta for prostate tumors really low?. Int J Radiat Oncol Biol Phys 50 (2001) 1021-1031
36. King C.R., and Mayo C.S. Is the prostate α/β ratio of 1.5 from Brenner and Hall a modeling artifact?. Int J Radiat Oncol Biol Phys 47 (2000) 536-538
37. Nutting C.M., Corbishley C.M., Sanchez-Nieto B., et al. Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapy. Br J Radiol 75 (2002) 151-161
38. Speight J.L., and Roach III M. Advances in the treatment of localized prostate cancer: the role of anatomic and functional imaging in men managed with radiotherapy. J Clin Oncol 25 (2007) 987-995